Log In
Print
BCIQ
Print
Print this Print this
 

KHK4083

  Manage Alerts
Collapse Summary General Information
Company Kyowa Hakko Kirin Co. Ltd.
DescriptionImmunomodulator
Molecular Target
Mechanism of ActionImmune modulation
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard Indication Autoimmune (unspecified)
Indication DetailsTreat autoimmune diseases
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today